Screener
Polaryx Therapeutics, Inc. PLYX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The source filing: Polaryx Therapeutics, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 14, 2026, 8:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-056973
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash flows used in operating activities: | ||
| Stock-based compensation | 467 | 4,451 |
| Changes in assets and liabilities which provided (used) cash: | ||
| Prepaid expenses and other current assets | (395) | (4) |
| Accounts payable | 380 | (17) |
| Due to related party | 7 | — |
| Accrued expenses – related party | 22 | — |
| Accrued expenses and other current liabilities | — | (87) |
Item 1. Financial Statements (Unaudited) Item 1. Financial Statements
FAQ
- What is Polaryx Therapeutics, Inc.'s prepaid & other current?
- Polaryx Therapeutics, Inc. (PLYX) reported prepaid & other current of $395K in Q1 2026.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Polaryx Therapeutics, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude